MedTrace Logo

Communication Effectiveness in Cancer Treatment

NCT02197091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-07-03

No results posted yet for this study

Summary

This pilot research trial studies communication effectiveness in cancer treatment. Studying how well patients and their doctors communicate about the treatment being given for cancer may help improve the decisions that patients and physicians make together.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

questionnaire administration

Ancillary studies

OTHER

medical chart review

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Katharine Duckworth, PhD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02197091 on ClinicalTrials.gov